These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 2573746)
1. [Analysis of P-glycoprotein in patients with acute leukemias by flow cytometry]. Funato T; Bando Y; Kato H; Tokuhiro H; Shimoda Y; Ohtani H Rinsho Byori; 1989 Aug; 37(8):899-904. PubMed ID: 2573746 [TBL] [Abstract][Full Text] [Related]
2. Detection of P-glycoprotein in human leukemias using monoclonal antibodies. Mattern J; Efferth T; Bak M; Ho AD; Volm M Blut; 1989 Apr; 58(4):215-7. PubMed ID: 2565123 [TBL] [Abstract][Full Text] [Related]
3. [Expression of multidrug resistance 1 and correlation with clinical drug resistance in acute leukemia]. Asou N; Nishikawa K; Suzushima H; Takatsuki K Nihon Rinsho; 1992 Jun; 50(6):1400-6. PubMed ID: 1355571 [TBL] [Abstract][Full Text] [Related]
4. [Expression of P-glycoprotein (multidrug-resistance gene product) in haematological tumors]. Funato T; Bando Y; Iwasaki M; Shimamoto Y; Kasai K; Tokuhiro H; Ohtani H Rinsho Byori; 1989 Jul; 37(7):779-83. PubMed ID: 2575182 [TBL] [Abstract][Full Text] [Related]
5. Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. Herweijer H; Sonneveld P; Baas F; Nooter K J Natl Cancer Inst; 1990 Jul; 82(13):1133-40. PubMed ID: 1972761 [TBL] [Abstract][Full Text] [Related]
6. Feasibility of using quinine, a potential multidrug resistance-reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia. Solary E; Caillot D; Chauffert B; Casasnovas RO; Dumas M; Maynadie M; Guy H J Clin Oncol; 1992 Nov; 10(11):1730-6. PubMed ID: 1357108 [TBL] [Abstract][Full Text] [Related]
7. Mdr1 gene expression in childhood acute lymphoblastic leukemias and lymphomas: a critical evaluation by four techniques. Brophy NA; Marie JP; Rojas VA; Warnke RA; McFall PJ; Smith SD; Sikic BI Leukemia; 1994 Feb; 8(2):327-35. PubMed ID: 7905944 [TBL] [Abstract][Full Text] [Related]
8. Atypical multidrug resistance in CCRF-CEM cells selected for high level methotrexate resistance: reactivity to monoclonal antibody C219 in the absence of P-glycoprotein expression. Norris MD; Haber M; King M; Davey RA Biochem Biophys Res Commun; 1989 Dec; 165(3):1435-41. PubMed ID: 2575383 [TBL] [Abstract][Full Text] [Related]
10. Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents. Hait WN; Choudhury S; Srimatkandada S; Murren JR J Clin Invest; 1993 May; 91(5):2207-15. PubMed ID: 8098047 [TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein in acute nonlymphoblastic leukemia and in the blastic crisis of myeloid leukemia. Carulli G; Petrini M; Marini A; Ambrogi F N Engl J Med; 1988 Sep; 319(12):797-8. PubMed ID: 2901038 [No Abstract] [Full Text] [Related]
12. [Multidrug resistance (MDR) to cytostatics in proliferative diseases of the hematopoietic system]. Adamczyk-Cioch MB; Dmoszyńska-Giannopoulau A Pol Arch Med Wewn; 1992 Mar; 87(3):183-90. PubMed ID: 1355902 [No Abstract] [Full Text] [Related]
13. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies. Van Acker KL; Van Hove LM; Boogaerts MA Cytometry; 1993 Oct; 14(7):736-46. PubMed ID: 7902231 [TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein (P-170) expression in acute leukemias. Abd El-Ghaffar HA; Aladle DA; Farahat SE; Abd El-Hady N Hematology; 2006 Feb; 11(1):35-41. PubMed ID: 16522547 [TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia. Carulli G; Petrini M; Marini A; Vaglini F; Caracciolo F; Grassi B Haematologica; 1990; 75(6):516-21. PubMed ID: 1982999 [TBL] [Abstract][Full Text] [Related]
16. Decreased P-glycoprotein expression in multidrug-sensitive and -resistant human myeloma cells induced by the cytokine leukoregulin. Evans CH; Baker PD Cancer Res; 1992 Nov; 52(21):5893-9. PubMed ID: 1356622 [TBL] [Abstract][Full Text] [Related]
17. Expression of multidrug resistance gene (MDR-1) in human normal leukocytes. Damiani D; Michieli M; Michelutti A; Geromin A; Raspadori D; Fanin R; Savignano C; Giacca M; Pileri S; Mallardi F Haematologica; 1993; 78(1):12-7. PubMed ID: 8098310 [TBL] [Abstract][Full Text] [Related]
18. Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia. Cavalcanti GB; Vasconcelos FC; Pinto de Faria G; Scheiner MA; de Almeida Dobbin J; Klumb CE; Maia RC Cytometry B Clin Cytom; 2004 Sep; 61(1):1-8. PubMed ID: 15351976 [TBL] [Abstract][Full Text] [Related]
19. High-level expression of P-glycoprotein and 85 kD protein as assessed by flow cytometry and immunocytochemistry in leukemias and malignant lymphomas. Umeda Y; Tsuruo T; Mori S; Arimori S; Sugawara I Tokai J Exp Clin Med; 1990 May; 15(2-3):179-87. PubMed ID: 1983371 [TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of P-glycoprotein in normal and leukemic cells. Tiirikainen MI; Syrjälä MT; Jansson SE; Krusius T Ann Hematol; 1992 Sep; 65(3):124-30. PubMed ID: 1356449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]